In ovarian carcinoma, overexpression of eIF5A2 was detected in 7% cystadenomas, 30% borderline tumors, and 53% invasive carcinomas, as opposed to normal expression in normal ovaries [177]. The gene discussed is EIF5A2; the disease is ovarian carcinoma.